US Patent Issued to Acceleron Pharma on July 7 for "ALK7 binding proteins and uses thereof" (Massachusetts, New Hampshire Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,998, issued on July 7, was assigned to Acceleron Pharma Inc. (Rahway, N.J.).

"ALK7 binding proteins and uses thereof" was invented by John Knopf (Cambridge, Mass.), Jonathan Belk (Lebanon, N.H.), Nathan J. Sharkey (Lebanon, N.H.), Ravindra Kumar (Action, Mass.), Asya Grinberg (Lexington, Mass.), Dianne Sako (Medford, Mass.), Roselyne Castonguay (Watertown, Mass.) and Yossi Dagon (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides ALK7-binding proteins such as anti-ALK7 antibodies, and compositions and methods for making the ALK7-binding proteins. In certain embodiments the ALK7-binding proteins inhibit, or antago...